Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-11 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-11 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-06 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |